Abiopharma

Agilysys to Participate in the William Blair 46th Annual Growth Stock Conference

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

8x8, Inc. Announces Participation in Evercore Global TMT Conference

ROLLINS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zeta Global Announces Olympic Gold Medalist, Entrepreneur and Founder Lindsey Vonn as Second Zeta Live 2026 Keynote Speaker

Credo Technology Group Holding Ltd Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Central Securities Corporation Declares Dividend

HPE Reports Fiscal 2026 Second Quarter Results

Forgent Power Solutions Announces Closing of Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares